Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 16Triple Negative Breast Neoplasms 4Cardiotoxicity 2Primary Breast Cancer 1Pathologic Complete Response 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms 1HER2-negative Breast Cancer 1Cardiovascular Diseases 1Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

palbociclib 2Blood Pressure 2xinmailong 1ribociclib 1abemaciclib 1Vitamin D 1Social Determinants of Health 1Rivaroxaban 1Restraint, Physical 1Raloxifene Hydrochloride 1Quality of Life 1Progestins 1Progesterone 1Positron-Emission Tomography 1Patient Navigation 1Linseed Oil 1Hormone Replacement Therapy 1High-Intensity Interval Training 1Heart Rate 1Heart Function Tests 1Genetic Testing 1Exercise 1Estrogens 1Estrogen Replacement Therapy 1Estradiol 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium 1Anthracyclines 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cardiovascular Diseases × Anthracyclines × Breast × Clear all
NCT04568161 2025-04-03

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

University of Sao Paulo General Hospital

Phase NA Completed
15 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡